|Bid||0.00 x 800|
|Ask||0.00 x 1800|
|Day's range||134.96 - 138.23|
|52-week range||112.07 - 305.21|
|Beta (5Y monthly)||0.98|
|PE ratio (TTM)||35.16|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||23 Nov 2012|
|1y target est||N/A|
NEUCHATEL, Switzerland, May 23, 2022--A study investigated the ability of Masimo PVi® to guide ER triage decisions for pediatric patients with obstructive respiratory disease.
IRVINE, Calif., May 03, 2022--Masimo (Nasdaq: MASI) today announced its financial results for the first quarter of 2022, ended April 2, 2022.
IRVINE, Calif., May 02, 2022--The Masimo W1™, the first health watch to offer accurate, continuous measurements, is being introduced in a limited market release for consumers.